Testing effectiveness (Phase 2)Study completedNCT00003110What this trial is testingBleomycin in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT01016990What this trial is testingValproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Auxilio Mutuo Cancer Center 52
Early research (Phase 1)Active Not RecruitingNCT04872790What this trial is testingVenetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Mixed Phenotype Acute Leukemia+2 more OHSU Knight Cancer Institute 20
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Active Not RecruitingNCT03960840What this trial is testingPhase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaDiffuse Large B-cell Lymphoma+2 more Novartis Pharmaceuticals 217
Early research (Phase 1)Looking for participantsNCT06080191What this trial is testingAllogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Bambino Gesù Hospital and Research Institute 24
Very early researchStudy completedNCT01184885What this trial is testingA Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyWho this might be right forLymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Testing effectiveness (Phase 2)Ended earlyNCT01378871What this trial is testingA Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/LymphomaWho this might be right forAdult T Cell LeukemiaAdult T Cell Lymphoma Amit Verma 1
Early research (Phase 1)Study completedNCT05775406What this trial is testingSafety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid TumorsWho this might be right forMyeloid MalignanciesAcute Lymphocytic LeukemiaLymphomas+1 more Kymera Therapeutics, Inc. 52
Early research (Phase 1)Ended earlyNCT03519984What this trial is testingEphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlasts 5 Percent or More of Bone Marrow Nucleated CellsMyelodysplastic/Myeloproliferative Neoplasm+8 more University of Southern California 3
Not applicableStudy completedNCT05849792What this trial is testingInternet-based Physical Activities Randomized Controlled Trial in Mild/Moderate Depression Participants: SONRIE ProjectWho this might be right forExercisePhysical FitnessDepression+2 more University of Cadiz 80
Testing effectiveness (Phase 2)Looking for participantsNCT06698003What this trial is testingMogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Who this might be right forT-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more Memorial Sloan Kettering Cancer Center 134
Large-scale testing (Phase 3)UnknownNCT00003924What this trial is testingInterferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaWho this might be right forLymphoma Lymphoma Study Association 360
Large-scale testing (Phase 3)Active Not RecruitingNCT06475820What this trial is testingPreventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With HemoblastosisWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+2 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Early research (Phase 1)Study completedNCT00217646What this trial is testingSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia+21 more National Cancer Institute (NCI) 36
Not applicableStudy completedNCT03595969What this trial is testingAssociation Between Mitochondrial DNA Content and Risk of Acute LeukemiaWho this might be right forLymphoblastic Leukemia in Children Air Force Military Medical University, China 300
Testing effectiveness (Phase 2)Study completedNCT00052442What this trial is testing10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's LymphomaWho this might be right forLymphoma Spectrum Pharmaceuticals, Inc 72
Not applicableStudy completedNCT00003196What this trial is testingLow-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821610What this trial is testingA Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)Who this might be right forAcute Lymphoblastic Leukemia University of Birmingham 242
Testing effectiveness (Phase 2)Looking for participantsNCT06738368What this trial is testingEtoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeT Acute Lymphoblastic Leukemia University of Washington 30